---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-056731"
form_type: "8-K"
ticker: "CBUS"
cik: "0001705843"
company_name: "Cibus, Inc."
filed_at: "2026-08-13T20:14:58+00:00"
generated_at: "2026-08-13T20:16:15.154465+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Cibus Q2 net loss $22.1M, cash $20.4M, EU gene-editing rule favorable, Interoc expands to 5 Rice traits

## Summary
- Net loss $22.1M vs $26.6M YoY; EPS -$0.29 vs -$0.61.
- Cash $20.4M; expects to fund into early Q1 2027; quarterly net cash usage down 19% QoQ, 31% YoY.
- EU approved gene-edited crops as conventional (June 2026); supports Rice and other programs.
- Interoc amended LOI to expand from 2 to 5 Rice traits; potential 2028 launch.
- Craig Wichner appointed CEO effective June 8, 2026; Peter Beetham remains President/COO.

## SEC filing metadata
- accession: 0001628280-26-056731
- form_type: 8-K
- ticker: CBUS
- cik: 0001705843
- company_name: Cibus, Inc.
- filed_at: 2026-08-13T20:14:58+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1705843/000162828026056731/0001628280-26-056731-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1705843/000162828026056731/cbus-20260813.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-056731
- JSON: https://secwatch.observer/filing/0001628280-26-056731.json
- Plain text: https://secwatch.observer/filing/0001628280-26-056731.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.